To more fully delineate the mechanisms by which ARHGEF12 promotes chemoresistance in BLCA, future research should integrate multidimensional lines of evidence to corroborate and extend the current experimental results. The gene discussed is ARHGEF12; the disease is bladder transitional cell carcinoma.